Just finished facilitating the #ASH22 #healthequity studio with Irum Khan on recognizing and addressing #ImplicitBias. Actions: be aware of yours, speak up when you see it, ask about SDH, use inclusive language (in charts too).

Abst 0933 Multiomic single cell analysis of ven-gilt aml treated pts suggests all RAS mut were present at v low levels at diagnosis in cells containing FLT3 mut. So expansion shaped by therapy AND inc expression of monocytic surf markers w treatment #ASH22 #leusm Vanessa Kennedy

Thats over 10 years of Aga Khan University alumni in that picture! thank you for bringing us together and look forward to growing the group in years to come. #ASH22

Thanks Jazz Pharmaceuticals for sponsoring the inaugural Women in Leukemia event! And thank you to the women AND men who came out in support! Eunice Wang MD Amy DeZern Dr. Uma Borate: Associate Professor Geoffrey Uy

Fascinating animal data from Prof. Shane Crotty that unbeknownst to us, memory b cells are training to become 1000 fold more potent against antigenic variants in germinal center arsenals upto 6 months after vaccine exposure #ASH2022

It’s finally here! 🥹 evidence.nejm.org/doi/full/10.10… Thanks to my collaborators Abhishek Niroula Marlise R. Luskin MD, MSCE @ColemanLindsley Chris Gibson Siddhartha Jaiswal Alex Bick Pradeep Natarajan Caitlyn Vlasschaert Luca Malcovati, Donna Neuberg, Waihay Wong, Rich Stone, Dan DeAngelo and of course Ben Ebert

Looking forward to a great exchange of practice points and experiences in managing myeloid malignancies from a global oncology perspective. Lurie Cancer Center ACS Research

Important work showing us that dogmatic clinical trial eligibility criteria need to be individually re-examined in the interest of inclusivity. Thank you Andrew Hantel for including us.

Exciting collab w DrTyner ⁦OHSU Knight Cancer Institute⁩ and ⁦⁩ ⁦University of Illinois Cancer Center⁩ leveraging BeatAML data to show FOXM1 underlies chemosensitivty in NPM1mut AML and investigating a novel FOXM1 inhibitor ⁦ACS Research⁩ ⁦⁦⁦Lurie Cancer Center⁩ nam04.safelinks.protection.outlook.com/?url=https%3A%…

Honored to continue our teamwork to establish a link between social and physical environment and #AML biology and outcomes. Anand Patel UChicago Leukemia Program Carlos Galvez University of Illinois Cancer Center Dr. Tsai Loyola Heme/Onc Jessica Altman, MD Lurie Cancer Center Dr. Larson RUSH Cancer Center & Dr. Zia Cook County Health Internal Medicine Residency

Congratulations! Linking macroenvironment to cancer outcomes is so challenging. thank you for sharing! I am going to town with my highlighter 😀…

A prospective approach linking individual level pt reported SDOH data to early adverse AML outcomes. Proud of Eshana Shah for an excellent oral abstract and the dedicated efforts of leukemia teams, trainees and patients University of Illinois Cancer Center and Lurie Cancer Center

#SCHD24 call for abstracts in the following categories: ▶️Basic science research ▶️Clinical research ▶️Quality-of-care research ▶️Outcomes research ▶️Case reports and case-series education.binayfoundation.org/abstracts-2023 This annual meeting is one of the largest gatherings of cancer care

Incredible talk by Dr. Michele Andrasik about unpacking #disparities to inform action at #SCHD24 Beyond Trauma Foundation - take note of these key messages and remember that all our #meded learners need to be taught about disparities!

Fantastic line up Beyond Trauma Foundation #SCHD24 1-valuable trial implementation lesson from early covid trials to account for slower rate of BIPOC accrual due to access issues 2-effective communication around gender identity, race and ethnicity is first step to a therapeutic alliance

So excited for the event co-hosted by Lee Grimes Lab with the most amazing people coming from across the country to share their science! Irum Khan Jesse Plascak #AndrewHantel #GustavoRivero @MariaAmaya_27 Bailee Kain Isaiah Boateng The James at Ohio State - hope to see everyone there!!!

Thank you for your efforts in leading this innovative work Anand Patel and Andrew Palmer !

HbSS outcomes in LMIC, tolerability of novel agents in URMs and neighborhood effects on leukemia-outstanding talks by the Hematology Inclusion Pathway trainees. Great discussion by alumni and mentors #ASH24 University of Illinois Department of Medicine University of Illinois Cancer Center

Thank you Dr Grant for an insightful discussion on the multilevel barriers to stem cell transplant, highlighting the sobering statistics of persistent disparities and policy level changes that are needed to ensure equitable access to this key arm of leukemia therapy.

Really exciting to see the clinical culmination of your group’s earlier observations on BET inhibition potentiating JAK inhibitors in inflammation suppression in MF. Valuable clinical efficacy data in a disease where combination therapies are challenging.